AbX Biologics, Inc. — Form D/A
AbX Biologics, Inc. of CANTON, MA, a company, filed a Form D amendment with the SEC on 2019-10-11. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Other.
Offering
- Filed: 2019-10-11
- Form: D/A
- Accession: 0001783034-19-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 5
- Date of first sale: 2019-07-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-344776
Issuer
- Name: AbX Biologics, Inc.
- CIK: 0001783034
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 480 NEPONSET STREET, SUITE 10B, CANTON, MA, 02021
- Phone: 603-767-9155
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Garren Hilow | Director | Canton, MA |
| Garren Hilow | Executive Officer | Canton, MA |
Other filings by this issuer (1)
More